Table 3. In Vivo Pharmacokinetic Parameters for the TNF Drug, TNF-Diffused Tablet (Tenof), and TNF-SEDDS (F6) Formulation.
| parameters | TNF drug | TNF marketed (Tenof) | TNF-SEDDS (F3) |
|---|---|---|---|
| Cmax (μg/mL) | 25.69 ± 2.14 | 148.57 ± 2.54 | 415.26 ± 2.11 |
| Tmax (h) | 6.15 ± 1.15 | 3.02 ± 1.42 | 1.55 ± 1.18 |
| AUC0–72 (μg h/ml) | 174.23 ± 58.18 | 536.41 ± 131.54 | 11546.64 ± 139.82 |
| t1/2 (h) | 17.25 ± 1.24 | 17.28 ± 1.51 | 17.21 ± 1.33 |